Differential trafficking of the vesicular monoamine transporter-2 by methamphetamine and cocaine

European Journal of Pharmacology

Volumn 449, Issue 1-2, 2002, Pages 71-74

  Riddle, Evan L ^a   Topham, Matthew K ^b   Haycock, John W ^c   Hanson, Glen R ^a   Fleckenstein, Annette E ^a  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

(Rat); Cocaine; Methamphetamine; Trafficking; VMAT 2 (vesicular monoamine transporter 2)

Indexed keywords

CARRIER PROTEIN; COCAINE; METHAMPHETAMINE; PSYCHOSTIMULANT AGENT; UNCLASSIFIED DRUG; VESICLUAR MONOAMINE TRANSPORTER 2; CENTRAL STIMULANT AGENT; MEMBRANE PROTEIN; NEUROPEPTIDE; VESICULAR AMINE TRANSPORTER; VESICULAR MONOAMINE TRANSPORTER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL FRACTIONATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG EFFECT; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT; RAT; SYNAPTOSOME; ANIMAL; METABOLISM; NEOSTRIATUM; SPRAGUE DAWLEY RAT; SYNAPSE VESICLE;

ANIMAL; CENTRAL NERVOUS SYSTEM STIMULANTS; COCAINE; MALE; MEMBRANE GLYCOPROTEINS; METHAMPHETAMINE; NEOSTRIATUM; PRESYNAPTIC TERMINALS; RATS; RATS, SPRAGUE-DAWLEY; SUPPORT, U.S. GOV'T, P.H.S.; SYNAPTIC VESICLES; ANIMALS; MEMBRANE TRANSPORT PROTEINS; NEUROPEPTIDES; VESICULAR BIOGENIC AMINE TRANSPORT PROTEINS; VESICULAR MONOAMINE TRANSPORT PROTEINS;

EID: 0037008254     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(02)01985-4     Document Type: Article

References (18)

1. Proteins involved in synaptic vesicle trafficking
2. Age-related differential recovery rates of rat striatal D-1 dopamine receptors following irreversible inactivation
3. Methamphetamine rapidly decreases vesicular dopamine uptake
4. Cocaine-induced increases in vesicular dopamine uptake: Role of dopamine receptors
5. Regulation of the vesicular monoamine transporter-2: A novel mechanism for cocaine and other psychostimulants
6. Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress
7. Recovery of dopamine transporter binding and function after intrastriatal administration of the irreversible inhibitor RTI-76 {3β-(3-ρ-chlorophenyl)tropan-2β carboxylic acid ρ-isothiocyanatophenylethyl ester hydrochloride}
8. Rapid and reversible effects of methamphetamine on dopamine transporters
9. Differential effects of stimulants on monoaminergic transporters: Pharmacological consequences and implications for neurotoxicity
10. Reduced striatal vesicular monoamine transporters after neurotoxic but not after behabiorally-sensitizing doses of methamphetamine
11. Analysis of VMAT2 binding after methamphetamine or MPTP treatment: Disparity between homogenates and vesicle preparations
12. Increased in vivo phosphorylation state of neuromodulin and synapsin I in striatum from rats treated with repeated amphetamine
13. Amphetamine increases the phosphorylation of neuromodulin and synapsin I in rat striatal synaptosomes
14. Peroxynitrite- and nitrite-induced oxidation of dopamine: Implications for nitric oxide in dopaminergic cell loss
15. Differential recovery rates of rat D2 dopamine receptors as a function of aging and chronic reserpine treatment following irreversible modification: A key to receptor regulatory mechanisms
16. Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport
17. Striatal dopamine nerve terminal markers in human, chronic methamphetamine users
18. Striatal dopamine, dopamine transporter, and vesicular monoamine transporter in chronic cocaine users